Stericycle Inc
Change company Symbol lookup
Select an option...
SRCL Stericycle Inc
TWTR Twitter Inc
CSTL Castle Biosciences Inc
LH Laboratory Corporation of America Holdings
ET Energy Transfer LP
BG Bunge Ltd
MSB Mesabi Trust
TRC Tejon Ranch Co
RMO Romeo Power Inc
RHI Robert Half International Inc
Go

Industrials : Commercial Services & Supplies | Small Cap Blend
Company profile

Stericycle, Inc. is a business-to-business services company. The Company serves customers in the United States and approximately 16 other countries worldwide with solutions for regulated waste and compliance services and secure information destruction services. The Company operates through two segments: Regulated Waste and Compliance Services, and Secure Information Destruction Services. Regulated Waste and Compliance Services segment provides its services to the customers in the United States, Brazil, Canada, Ireland, the Netherlands, Portugal, the Republic of Korea, Romania, Spain and the United Kingdom. Secure Information Destruction Services segment under the Shred-it brand provides its services in the United States, Australia, Belgium, Canada, France, Germany, Ireland, Luxembourg, the Netherlands, Portugal, Spain, Singapore and the United Kingdom. Secure Information Destruction Services are also provided in the United Arab Emirates through a joint venture.

Closing Price
$43.68
Day's Change
0.74 (1.72%)
Bid
--
Ask
--
B/A Size
--
Day's High
43.98
Day's Low
42.80
Volume
(Below Average)
Volume:
358,771

10-day average volume:
405,749
358,771

Dexcom Reports Second Quarter 2022 Financial Results

4:03 pm ET July 28, 2022 (BusinessWire) Print

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2022.

Second Quarter 2022 Financial Highlights:

Revenue grew 17% versus the same quarter of the prior year to $696.2 million on a reported basis and 16% on an organic(1) basis. U.S. revenue growth of 11% and international revenue growth of 39% on a reported basis. International revenue growth was 34% on an organic(1) basis. GAAP operating income of $77.0 million or 11.1% of revenue, a decrease of 590 basis points compared to the second quarter of 2021. Non-GAAP operating income* of $101.9 million or 14.6% of revenue, a decrease of 250 basis points compared with the same quarter of the prior year.

Strategic Highlights:

Advanced CGM portfolio strategy, including the launches of Dexcom ONE in the UK and Spain. Showcased the present and future potential of CGM technology with a robust research presence at the Advanced Technologies and Treatments for Diabetes (ATTD) and American Diabetes Association (ADA) conferences. Received CE Mark for an updated sensor algorithm, making the latest G7 sensor technology available to international markets. Subsequent to the end of the quarter, launched the Dexcom G6 mobile app in Spanish, providing more choice to users and eliminating a potential language barrier to optimal care.

"In the second quarter, Dexcom advanced a number of key initiatives, including the expansion of our CGM portfolio strategy in international markets," said Kevin Sayer, Dexcom's chairman, president and CEO. "We are excited for the rest of this year, particularly as we implement a broader launch of G7 in the coming weeks."

2022 Annual Guidance

The company is updating fiscal year 2022 revenue guidance, and reiterating guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin at the following levels:

Revenue of approximately $2.86 - 2.91 billion (17-19% growth) Non-GAAP Gross Profit Margin of approximately 65% Non-GAAP Operating Margin of approximately 16% Adjusted EBITDA Margin of approximately 25%

Second Quarter 2022 Financial Results

Revenue: In the second quarter of 2022, worldwide revenue grew 17% to $696.2 million, up from $595.1 million in the second quarter of 2021. Volume growth in conjunction with strong new customer additions continues to be the primary driver of revenue growth as awareness of real-time CGM increases.

Gross Profit: Gross profit totaled $449.5 million or 64.6% of revenue for the second quarter of 2022, compared to $417.1 million or 70.1% of revenue in the second quarter of 2021.

Operating Income: GAAP operating income for the second quarter of 2022 was $77.0 million, compared to GAAP operating income of $101.0 million for the second quarter of 2021.

Non-GAAP operating income* for the second quarter of 2022 was $101.9 million, compared to non-GAAP operating income of $101.5 million for the second quarter of 2021.

Net Income and Net Income per Share: GAAP net income was $50.9 million, or $0.12 per diluted share, for the second quarter of 2022, compared to GAAP net income of $78.4 million, or $0.19 per diluted share, for the same quarter of 2021.

Non-GAAP net income* was $69.5 million, or $0.17 per diluted share, for the second quarter of 2022, compared to non-GAAP net income of $75.1 million, or $0.19 per diluted share, for the same quarter of 2021. The second quarter 2022 non-GAAP amount excludes $13.8 million of business transition and related costs, $9.2 million of intellectual property litigation costs, $1.9 million of amortization of intangible assets, and $6.3 million of tax adjustments primarily related to excess tax benefits from stock compensation vesting.

Cash and Liquidity: As of June 30, 2022, Dexcom held $2.75 billion in cash, cash equivalents and marketable securities and our revolving credit facility remains undrawn. The cash balance represents significant financial and strategic flexibility as Dexcom continues to expand production capacity and explore new market opportunities.

________________
(1)                  Excludes non-CGM revenue acquired in conjunction with Dexcom's acquisition of its distributor in Australia and New Zealand, as well as the impact of foreign exchange. Excludes non-CGM revenue acquired in conjunction with Dexcom's acquisition of its distributor in Australia and New Zealand, as well as the impact of foreign exchange.
                                                                                                                                                                                  
                   * See Table E below for a reconciliation of these GAAP and non-GAAP financial measures.                                                                                                             See Table E below for a reconciliation of these GAAP and non-GAAP financial measures.

Conference Call

Management will hold a conference call today starting at 4:30 p.m. (Eastern Time). The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com by navigating to "Events and Presentations," and will be archived for future reference. To listen to the conference call, please dial (866) 374-5140 (US/Canada) or (404) 400-0571 (International) and use the confirmation number "24372094#" approximately five minutes prior to the start time.

Statement Regarding Use of Non-GAAP Financial Measures

This press release and the accompanying tables include non-GAAP financial measures. For a description of these non-GAAP financial measures, including the reasons management uses each measure, and reconciliations of these non-GAAP financial measures to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP), please see the section of the accompanying tables titled "About Non-GAAP Financial Measures" as well as the related Table E.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that are not purely historical regarding Dexcom's or its management's intentions, beliefs, expectations and strategies for the future, including statements with respect to the impacts of the COVID-19 pandemic on Dexcom, timing or acceptance of regulatory approvals and commercial launch of G7 and our outlook for the full year 2022. All forward-looking statements and reasons why results might differ included in this press release are made as of the date of this release, based on information currently available to Dexcom, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that may cause actual results to differ materially from Dexcom's current expectations are more fully described in Dexcom's Quarterly Report on Form 10-Q for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on July 28, 2022. Except as required by law, Dexcom assumes no obligation to update any such forward-looking statement after the date of this report or to conform these forward-looking statements to actual results.

                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                           DexCom, Inc.
                                                                                                                                                                                                              Table A
                                                                                                                                                                                                    Consolidated Balance Sheets
                                                                                                                                                                                               (In millions, except par value data)
                                                                                                                                                                                                            (Unaudited)
                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                            June 30,                               June 30,                                                 December 31,
                                                                                                                                                                                                                                             2022                                   2022                                                                          2021
                                                                                                                                                                                                                                     -------------------- ------------------------------------------------------                        ------------------------------------------------------
Assets                                                                                                                                                                                                                                                                                                    (As Adjusted)*
Current assets:                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                            $                    $          735.4                      $                    $        1,052.6  
    Cash and cash equivalents
                                                                                                                                                                                                                                                    2,019.4              1,678.6  
    Short-term marketable securities
                                                                                                                                                                                                                                                      560.8                514.3  
    Accounts receivable, net
                                                                                                                                                                                                                                                      339.5                357.3  
    Inventory
                                                                                                                                                                                                                                                      153.6                 81.6  
    Prepaid and other current assets
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                                                        3,808.7              3,684.4  
        Total current assets
Property and equipment, net                                                                                                                                                                                                                                                  942.9                801.8  
Operating lease right-of-use assets                                                                                                                                                                                                                                                 77.9                 88.1  
Goodwill                                                                                                                                                                                                                                                   25.6                 26.5  
Intangibles, net                                                                                                                                                                                                                                                   28.0                 31.5  
Deferred tax assets                                                                                                                                                                                                                                                  309.5                290.5  
Other assets                                                                                                                                                                                                                                                   24.8                 10.5  
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                                                                $                    $        5,217.4                      $                    $        4,933.3  
        Total assets
                                                                                                                                                                                                                                     ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
Liabilities and Stockholders' Equity                                                                                                                                                                                                                                                  
Current liabilities:                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                            $                    $          688.3                      $                    $          573.0  
    Accounts payable and accrued liabilities
                                                                                                                                                                                                                                                       94.8                125.2  
    Accrued payroll and related expenses
                                                                                                                                                                                                                                                       21.2                 20.5  
    Short-term operating lease liabilities
                                                                                                                                                                                                                                                        2.7                  2.1  
    Deferred revenue
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                                                          807.0                720.8  
        Total current liabilities
Long-term senior convertible notes                                                                                                                                                                                                                                               1,967.3              1,981.8  
Long-term operating lease liabilities                                                                                                                                                                                                                                               87.7                 98.6  
Other long-term liabilities                                                                                                                                                                                                                                                   99.5                 90.0  
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                                                        2,961.5              2,891.2  
        Total liabilities
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Commitments and contingencies                                                                                                                                                                                                                                                                                
Stockholders' equity:                                                                                                                                                                                                                                                                 
Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at June 30, 2022 and December 31, 2021                                                                                                                                 --       --  
Common stock, $0.001 par value, 800.0 million shares authorized; 392.9 million and 392.6 million shares issued and outstanding, respectively, at June 30, 2022; and 391.4 million and 388.0 million shares issued and outstanding, respectively, at December 31, 2021                0.4                  0.4  
Additional paid-in capital                                                                                                                                                                                                                                                2,028.9              2,108.7  
Accumulated other comprehensive income (loss)                                                                                                                                                                                                                                      (23.0 )                                   0.5  
Retained earnings                                                                                                                                                                                                                                                  286.9                138.7  
Treasury stock, at cost; 0.3 million shares at June 30, 2022 and 3.4 million shares at December 31, 2021                                                                                                                                                                           (37.3 )                                (206.2 )
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
                                                                                                                                                                                                                                                        2,255.9              2,042.1  
        Total stockholders' equity
                                                                                                                                                                                                                                     -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
* We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split. We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split.
                                                                                                                                                                           DexCom, Inc.
                                                                                                                                                                              Table B
                                                                                                                                                               Consolidated Statements of Operations
                                                                                                                                                               (In millions, except per share data)
                                                                                                                                                                            (Unaudited)
                                                                                                                                                                                                              
                                Three Months Ended                                                            Three Months Ended                                                             Six Months Ended                                                           Six Months Ended
                                                        June 30,                                                                      June 30,                                                                      June 30,                                                                   June 30,
                                                  -------------------- --------------------------------------------------------------------------------------------------------------------------------       -------------------- -------------------------------------------------------------------------------------------------------------------------
                                       2022                                   2022                                   2021                                   2021                                   2022                                2022                               2021                                   2021
                                                  -------------------- ------------------------------------------------------   -------------------- ------------------------------------------------------   -------------------- -----------------------------------------------   -------------------- ------------------------------------------------------
                                                                          (As Adjusted)*                         (As Adjusted)*                                                          (As Adjusted)*                         (As Adjusted)*
Revenue                                                              $                    $          696.2                      $                    $          595.1                      $                    $ 1,325.0                      $                    $        1,100.1  
Cost of sales                                                  246.7                178.0         477.4                339.1  
                                                  -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- -------------- --------------------
                                                               449.5                417.1         847.6                761.0  
    Gross profit
Operating expenses:                                                                                                                                                   
                                                               121.7                129.1         257.6                238.5  
    Research and development
                                                                 1.9                  0.5           3.9                  1.0  
    Amortization of intangible assets
                                                               248.9                186.5         467.8                374.6  
    Selling, general and administrative
                                                  -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- -------------- --------------------
                                                               372.5                316.1         729.3                614.1  
    Total operating expenses
                                                  -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- -------------- --------------------
Operating income                                                77.0                101.0         118.3                146.9  
Interest expense                                                (4.7 )                                  (4.8 )                           (9.3 )                                  (9.5 )
Income from equity investments                        --       --           0.2       --  
Interest and other income, net                                   3.0                  0.9           2.2                  1.0  
                                                  -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- -------------- --------------------
Income before income taxes                                      75.3                 97.1         111.4                138.4  
Income tax expense (benefit)                                    24.4                 18.7         (36.8 )                                   3.5  
                                                  -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- ------- -------------------- -------------------- -------------------- -------------- --------------------
Net income                                                           $                    $           50.9                      $                    $           78.4                      $                    $   148.2                      $                    $          134.9  
                                                  ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ======= ==================== ==================== ==================== ============== ====================
                                                                                                                                                   
Basic net income per share                                           $                    $           0.13                      $                    $           0.20                      $                    $    0.38                      $                    $           0.35  
                                                  ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ======= ==================== ==================== ==================== ============== ====================
Shares used to compute basic net income per share              392.5                386.9         390.7                386.1  
                                                  ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ======= ==================== ==================== ==================== ============== ====================
Diluted net income per share                                         $                    $           0.12                      $                    $           0.19                      $                    $    0.36                      $                    $           0.33  
                                                  ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ======= ==================== ==================== ==================== ============== ====================
* We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split. We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. All periods presented have also been adjusted to reflect the four-for-one stock split.
                                                                                                                                                    DexCom, Inc.
                                                                                                                                                       Table C
                                                                                                                                                Revenue by Geography
                                                                                                                                                (Dollars in millions)
                                                                                                                                                     (Unaudited)
                                                                                                                                                                  
                                                           Three Months Ended                                                                                                         Six Months Ended
                                                                                                      June 30,                                                                                                                                     June 30,
                                               ----------------------------------------------------------------------------------------------------------------                            ------------------------------------------------------------------------------------------------------------------
                               2022                                               2021                                                2022                                                2021
                                               ----------------------------------------------                        ----------------------------------------------                        -----------------------------------------------                        -----------------------------------------------
U.S. revenue                                 $                    $  511.0                      $                    $  461.5                      $                    $   962.2                      $                    $   842.7  
                                  11 %                            26 %                             14 %                             28 %
    Year over year growth
                                  73 %                            78 %                             73 %                             77 %
    % of total revenue
                                                                                                           
International revenue                        $                    $  185.2                      $                    $  133.6                      $                    $   362.8                      $                    $   257.4  
                                  39 %                            58 %                             41 %                             30 %
    Year over year growth
                                  27 %                            22 %                             27 %                             23 %
    % of total revenue
                                                                                                           
Total revenue (1)                            $                    $  696.2                      $                    $  595.1                      $                    $ 1,325.0                      $                    $ 1,100.1  
(1) The sum of the revenue components may not equal total revenue due to rounding. The sum of the revenue components may not equal total revenue due to rounding.
                                                                                                                                                       DexCom, Inc.
                                                                                                                                                          Table D
                                                                                                                                                   Revenue by Component
                                                                                                                                                   (Dollars in millions)
                                                                                                                                                        (Unaudited)
                                                                                                                                                                         
                                                                  Three Months Ended                                                                                                         Six Months Ended
                                                                                                             June 30,                                                                                                                                     June 30,
                                                      ----------------------------------------------------------------------------------------------------------------                            ------------------------------------------------------------------------------------------------------------------
                                      2022                                               2021                                                2022                                                2021
                                                      ----------------------------------------------                        ----------------------------------------------                        -----------------------------------------------                        -----------------------------------------------
Sensor and other revenue (1) (2)                    $                    $  597.7                      $                    $  494.5                      $                    $ 1,140.9                      $                    $   918.8  
                                         21 %                            36 %                             24 %                             33 %
    Year over year growth
                                         86 %                            83 %                             86 %                             84 %
    % of total revenue
                                                                                                                  
Hardware revenue (1)(3)                             $                    $   98.5                      $                    $  100.6                      $                    $   184.1                      $                    $   181.3  
                                         (2 )%                           15 %                              2 %                              8 %
    Year over year growth
                                         14 %                            17 %                             14 %                             16 %
    % of total revenue
                                                                                                                  
Total revenue (4)                                   $                    $  696.2                      $                    $  595.1                      $                    $ 1,325.0                      $                    $ 1,100.1  
(1) Includes allocated subscription revenue.                                       Includes allocated subscription revenue.
(2) Includes services, freight, accessories, Non-CGM acquired revenue, etc.        Includes services, freight, accessories, Non-CGM acquired revenue, etc.
(3) Includes transmitter and receiver revenue.                                     Includes transmitter and receiver revenue.
(4) The sum of the revenue components may not equal total revenue due to rounding. The sum of the revenue components may not equal total revenue due to rounding.
                                                                                                                                                                                  DexCom, Inc.
                                                                                                                                                                                     Table E
                                                                                                                                                      Itemized Reconciliation Between GAAP and Non-GAAP Financial Measures
                                                                                                                                                                      (In millions, except per share data)
                                                                                                                                                                                   (Unaudited)
                                                                                                                                                                                                                        
                                                                                                  Three Months Ended                                                                                                                        Six Months Ended
                                                                                                                                             June 30,                                                                                                                                                    June 30,
                                                                              --------------------------------------------------------------------------------------------------------------------------------                            --------------------------------------------------------------------------------------------------------------------------------
                                                                  2022                                                       2021                                                       2022                                                       2021
                                                                              ------------------------------------------------------                        ------------------------------------------------------                        ------------------------------------------------------                        ------------------------------------------------------
                                                                                                     (As Adjusted)*                                                                                     (As Adjusted)*
GAAP operating income                                                       $                    $           77.0                      $                    $          101.0                      $                    $          118.3                      $                    $          146.9  
Amortization of intangible assets                                       1.9                  0.5                  3.9                  1.0  
Business transition and related costs (1)                              13.8       --                 13.8       --  
Intellectual property litigation costs (2)                              9.2       --                 16.2       --  
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Non-GAAP operating income                                                   $                    $          101.9                      $                    $          101.5                      $                    $          152.2                      $                    $          147.9  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
GAAP net income                                                             $                    $           50.9                      $                    $           78.4                      $                    $          148.2                      $                    $          134.9  
Business transition and related costs (1)                              13.8       --                 13.8       --  
Depreciation and amortization                                          43.6                 23.5                 80.4                 44.4  
Intellectual property litigation costs (2)                              9.2       --                 16.2       --  
Income from equity investments (3)                           --       --                 (0.2 )                        --  
Share-based compensation                                               32.6                 31.6                 61.7                 59.6  
Interest expense and interest income                                    1.0                  4.4                  4.6                  8.6  
Income tax (benefit) expense                                           24.4                 18.7                (36.8 )                                   3.5  
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Adjusted EBITDA                                                             $                    $          175.5                      $                    $          156.6                      $                    $          287.9                      $                    $          251.0  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
GAAP net income                                                             $                    $           50.9                      $                    $           78.4                      $                    $          148.2                      $                    $          134.9  
Amortization of intangible assets                                       1.9                  0.5                  3.9                  1.0  
Business transition and related costs (1)                              13.8       --                 13.8       --  
Intellectual property litigation costs (2)                              9.2       --                 16.2       --  
Income from equity investments (3)                           --       --                 (0.2 )                        --  
Adjustments related to taxes (4)                                       (6.3 )                                  (3.8 )                                 (80.1 )                                 (28.3 )
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Non-GAAP net income                                                         $                    $           69.5                      $                    $           75.1                      $                    $          101.8                      $                    $          107.6  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
GAAP net income                                                             $                    $           50.9                      $                    $           78.4                      $                    $          148.2                      $                    $          134.9  
Interest expense on senior convertible notes, net of tax                1.6                  2.9                  5.5                  5.8  
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
GAAP net income used for diluted EPS, if-converted                          $                    $           52.5                      $                    $           81.3                      $                    $          153.7                      $                    $          140.7  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
Non-GAAP net income                                                         $                    $           69.5                      $                    $           75.1                      $                    $          101.8                      $                    $          107.6  
Interest expense on senior convertible notes, net of tax                1.2                  1.2       --       --  
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Non-GAAP net income used for diluted EPS, if-converted                      $                    $           70.7                      $                    $           76.3                      $                    $          101.8                      $                    $          107.6  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
GAAP diluted net income per share (5)                                       $                    $           0.12                      $                    $           0.19                      $                    $           0.36                      $                    $           0.33  
Amortization of intangible assets                            --       --                 0.01       --  
Business transition and related costs (1)                              0.03       --                 0.03       --  
Intellectual property litigation costs (2)                             0.02       --                 0.04       --  
Income from equity investments (3)                           --       --       --       --  
Adjustments related to taxes (4)                                      (0.02 )                                 (0.01 )                                 (0.20 )                                 (0.07 )
Impact of adjustment to GAAP diluted shares (6)              --       --                 0.01                 0.01  
                                                         -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- -------------------- -------------------- -------------------- -------------- --------------------
Non-GAAP diluted net income per share (5) (7)                               $                    $           0.17                      $                    $           0.19                      $                    $           0.25                      $                    $           0.27  
                                                         ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ==================== ==================== ==================== ============== ====================
                                                                                                                                                                 
GAAP diluted weighted-average shares outstanding                      421.4                427.1                429.1                426.8  
Non-GAAP diluted weighted-average shares outstanding                  410.5                406.4                402.2                398.1  
                                                                                                                                          DexCom, Inc.
                                                                                                                                       Table E (Continued)
                                                                                                              Itemized Reconciliation Between GAAP and Non-GAAP Financial Measures
                                                                                                                              (In millions, except per share data)
                                                                                                                                           (Unaudited)
                                                                                                                                                                
                                                                                          Three Months Ended                                                                        Six Months Ended
                                                                                                                                     June 30,                                                                                                    June 30,
                                                                                             ------------------------------------------------------------------------------------                          --------------------------------------------------------------------------------
                                                                     2022                                2021                                2022                              2021
                                                                                             ------------------------------                       ----------------------------------                       ------------------------------                       ------------------------------
                                                                                 (As Adjusted)*                                     (As Adjusted)*
Reconciliation of non-GAAP diluted weighted-average shares outstanding:                                                     
GAAP diluted weighted-average shares outstanding                                       421.4      421.4                  427.1          427.1                  429.1      429.1                  426.8      426.8  
Adjustment for dilutive impact of senior convertible notes due 2023 (8)                (18.9      (18.9 )                                   (20.7          (20.7 )                                   (18.9      (18.9 )                                   (20.7      (20.7 )
Adjustment for dilutive impact of senior convertible notes due 2025 (9)                  8.0        8.0         -- --                   (8.0       (8.0 )                                    (8.0       (8.0 )
                                                                        -------------------- ---------- -------------------- -------------------- -------------- -------------------- -------------------- ---------- -------------------- -------------------- ---------- --------------------
                   * We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. The adoption eliminates the non-cash interest expense related to the conversion features of the convertible notes beginning in the first quarter of 2020. All periods presented have also been adjusted to reflect the four-for-one stock split.                                                                                                                                                                                  We adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance (ASU 2020-06), which we adopted on a full retrospective basis. The adoption eliminates the non-cash interest expense related to the conversion features of the convertible notes beginning in the first quarter of 2020. All periods presented have also been adjusted to reflect the four-for-one stock split.
                                                                                                                                                                                                                                         
(1)                  Business transition and related costs are primarily related to consulting and expenses related to vacating a portion of the San Diego office space, including accelerated depreciation of tenant improvements.                                                                                                                                                                                                                                     Business transition and related costs are primarily related to consulting and expenses related to vacating a portion of the San Diego office space, including accelerated depreciation of tenant improvements.
(2)                  Represents costs related to a patent infringement lawsuit.                                                                                                                                                                                                                                     Represents costs related to a patent infringement lawsuit.
(3)                  Represents a gain from the sale of an equity investment.                                                                                                                                                                                                                                     Represents a gain from the sale of an equity investment.
(4)                  For the three months ended June 30, 2022, the tax adjustments were primarily related to the tax effect of non-GAAP adjustments for business transition and related costs and intellectual property litigation costs. For the six months ended June 30, 2022, the tax adjustments were primarily related to excess tax benefits recognized from share-based compensation for employees and the Verily regulatory milestone payment. For the three and six months ended June 30, 2021, tax adjustments were primarily related to the excess tax benefits from share-based compensation for employees. For the three months ended June 30, 2022, the tax adjustments were primarily related to the tax effect of non-GAAP adjustments for business transition and related costs and intellectual property litigation costs. For the six months ended June 30, 2022, the tax adjustments were primarily related to excess tax benefits recognized from share-based compensation for employees and the Verily regulatory milestone payment. For the three and six months ended June 30, 2021, tax adjustments were primarily related to the excess tax benefits from share-based compensation for employees.
(5)                  When our senior convertible notes are dilutive on a GAAP or non-GAAP basis, net income used for calculating GAAP and non-GAAP diluted net income per share includes an interest expense add back, net of tax, under the if-converted method.                                                                                                                                                                                                                                     When our senior convertible notes are dilutive on a GAAP or non-GAAP basis, net income used for calculating GAAP and non-GAAP diluted net income per share includes an interest expense add back, net of tax, under the if-converted method.
(6)                  The adjustment for the six months ended June 30, 2022 and June 30, 2021 is for the transition from GAAP diluted net loss per share to non-GAAP diluted net income per share due to our 2023 and 2025 senior convertible notes.                                                                                                                                                                                                                                     The adjustment for the six months ended June 30, 2022 and June 30, 2021 is for the transition from GAAP diluted net loss per share to non-GAAP diluted net income per share due to our 2023 and 2025 senior convertible notes.
(7)                  The sum of the non-GAAP diluted net income per share components may not equal the totals due to rounding.                                                                                                                                                                                                                                     The sum of the non-GAAP diluted net income per share components may not equal the totals due to rounding.
(8)                  Our 2023 senior convertible notes are dilutive on a GAAP basis and anti-dilutive on a non-GAAP basis for the three and six months ended June 30, 2022 and 2021. Our 2023 senior convertible notes are also hedged through an anti-dilutive bond hedge arrangement.                                                                                                                                                                                                                                     Our 2023 senior convertible notes are dilutive on a GAAP basis and anti-dilutive on a non-GAAP basis for the three and six months ended June 30, 2022 and 2021. Our 2023 senior convertible notes are also hedged through an anti-dilutive bond hedge arrangement.
(9)                  Our 2025 senior convertible notes are anti-dilutive on a GAAP basis and dilutive on a non-GAAP basis for the three months ended June 30, 2022. Our 2025 senior convertible notes are dilutive on a GAAP and non-GAAP basis for the three months ended June 30, 2021. Our 2025 senior convertible notes are dilutive on a GAAP basis and anti-dilutive on a non-GAAP basis for the six months ended June 30, 2022 and 2021.                                                                                                                                                                          Our 2025 senior convertible notes are anti-dilutive on a GAAP basis and dilutive on a non-GAAP basis for the three months ended June 30, 2022. Our 2025 senior convertible notes are dilutive on a GAAP and non-GAAP basis for the three months ended June 30, 2021. Our 2025 senior convertible notes are dilutive on a GAAP basis and anti-dilutive on a non-GAAP basis for the six months ended June 30, 2022 and 2021.

ABOUT NON-GAAP FINANCIAL MEASURES

The accompanying press release dated July 28, 2022 contains non-GAAP financial measures. These non-GAAP financial measures include non-GAAP gross profit, non-GAAP operating income (loss), non-GAAP net income (loss), and non-GAAP net income (loss) per share as well as adjusted EBITDA.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. We believe that they provide useful information about operating results, enhance the overall understanding of our operating performance and future prospects, and allow for greater transparency with respect to key metrics used by senior management in our financial and operational decision making. Our non-GAAP financial measures exclude amounts that we do not consider part of ongoing operating results when planning and forecasting and when assessing the performance of the organization and our senior management. We compute non-GAAP financial measures using the same consistent method from quarter to quarter and year to year. We may consider whether other significant items that arise in the future should be excluded from our non-GAAP financial measures.

We report non-GAAP financial measures in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles, differ from GAAP measures with the same names, and may differ from non-GAAP financial measures with the same or similar names that are used by other companies. We believe that non-GAAP financial measures should only be used to evaluate our results of operations in conjunction with the corresponding GAAP financial measures. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliations between these presentations, to more fully understand our business.

Management believes that presentation of operating results that excludes these items provides useful supplemental information to investors and facilitates the analysis of our core operating results and comparison of operating results across reporting periods. Management also believes that this supplemental non-GAAP information is therefore useful to investors in analyzing and assessing our past and future operating performance.

Table E reconciles the non-GAAP financial measures in the press release to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP).

We exclude the following items from non-GAAP financial measures for non-GAAP gross profit, non-GAAP operating income (loss), non-GAAP net income (loss), and non-GAAP net income (loss) per share:

Amortization of acquired intangible assets Business transition and related costs associated with acquisition, integration and business transition activities, including severance, relocation, consulting, leasehold exit costs, third party merger and acquisition costs, and other costs directly associated with such activities COVID-19 costs associated with the COVID-19 outbreak related to taking the necessary precautions for essential personnel to operate safely both in person as well as remotely. Costs incurred include items like incremental payroll costs, consulting support, IT infrastructure and facilities related costs Income or loss from equity investments Intellectual property litigation costs Litigation settlement costs Loss on extinguishment of debt associated with our senior convertible notes Adjustments related to taxes for the excluded items above, as well as excess benefits or tax deficiencies from stock-based compensation, and the quarterly impact of other discrete items

Adjusted EBITDA excludes non-cash operating charges for share-based compensation, depreciation and amortization as well as non-operating items such as interest income, interest expense, loss on extinguishment of debt, income and loss from equity investments, and income tax expense or benefit. For the reasons explained above, adjusted EBITDA also excludes business transition and related costs, COVID-19 costs, litigation settlement costs, and intellectual property litigation costs.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005300/en/

SOURCE: DexCom, Inc.

INVESTOR RELATIONS CONTACT:
Sean Christensen
Senior Director - Investor Relations and Corporate FP&A
investor-relations@dexcom.com 
(858) 203-6657

MEDIA CONTACT:
James McIntosh
(619) 884-2118
comtex tracking

COMTEX_411181006/1006/2022-07-28T16:03:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.